Mark Hair insider trades: Treace Medical Concepts (TMCI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 9, 2023 | TMCI | ↓ Sell | 1,040 | $24.41 | $25K | Direct | Mar 10, 2023 (1d) |
| May 18, 2022 | TCMI | ↑ Buy | 6,200 | $15.80 | $98K | Direct | May 20, 2022 (2d) |
| Apr 27, 2021 | TMCI | ↑ Buy | 10,000 | $17.00 | $170K | Direct | Apr 29, 2021 (2d) |
| Apr 27, 2021 | TMCI | ↑ Buy | 3,600 | $17.00 | $61K | by dependents | Apr 29, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TMCI insiders
Open-market trades in the last 12 months
About Mark Hair's insider trades
Mark Hair is Chief Financial Officer at Treace Medical Concepts (TMCI). Since Apr 27, 2021, Mark has reported 3 open-market purchases worth $329K and 1 sale worth $25K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), shares withheld for taxes (9 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TMCI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.